BIO, the biotechnology industry organization, has just announced that Michael J. Fox will the keynote speaker at the group’s annual meeting in Boston (May 6-9). The topic will be:
Driving the Development and Availability of Novel Therapies
There is a great need for creative approaches to speed translation of our significant investments in research and discovery into meaningful, patient-relevant advances in human health. This keynote and panel discussion will explore strategies and solutions to "de-risk" investment in novel therapeutics for the biotechnology industry and academia alike.
Driving the Development and Availability of Novel Therapies
There is a great need for creative approaches to speed translation of our significant investments in research and discovery into meaningful, patient-relevant advances in human health. This keynote and panel discussion will explore strategies and solutions to "de-risk" investment in novel therapeutics for the biotechnology industry and academia alike.
No comments:
Post a Comment